Plasma fibroblast growth factor 21 is associated with severity of nonalcoholic steatohepatitis in patients with obesity and type 2 diabetes
Journal of Clinical Endocrinology and Metabolism | Mar 15, 2019
Most read this week
Journal of Clinical Endocrinology and Metabolism | Mar 15, 2019